SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to significant price movement and high trading volume, sparking discussions about a potential short squeeze. The community is actively debating entry points, profit-taking strategies, and whether the stock will continue its upward trajectory, drawing comparisons to other high-flying stocks. Some traders are pointing to the company's low float and recent focus on AI-powered robotics as potential catalysts for continued momentum.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its Phase 2b trial, showing promising results in brain metastases imaging, with the community actively discussing the potential for a short squeeze and anticipating further details from an upcoming webinar. The stock's high trading volume and significant pre-market gains are fueling speculative interest, despite some concerns about potential pullbacks and short attacks. This surge is also drawing attention to the broader oncology radiopharmaceutical sector.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling following comments from President Trump, sparking high volatility. The community is debating the likelihood and timing of an executive order, with some anticipating a short squeeze, while others express skepticism and caution against "pump and dump" schemes. Overall, the discussion reflects a mix of hope and uncertainty surrounding the future of cannabis regulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, with the community citing overall negative sentiment towards AI as a key factor despite the company's prior deal with Microsoft. Some traders point to potential tax-loss harvesting and broader market concerns as contributing to the recent price action. Discussions also involve speculation about future catalysts and whether current levels represent a buying opportunity or further downside risk.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to chatter around its low float and potential for a significant price surge, with some comparing it to other recent low-float runners. Discussions also involve the company's fundamentals, potential news catalysts, and high borrow rate, leading to speculation about a possible short squeeze. Some traders are moving profits from other stocks into CLIK, anticipating a substantial upward movement.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as community members discuss the company's application to become a bank, potentially expanding its services to include small business loans and savings accounts.  Some see this as a game-changer with Federal Reserve backing and potential for long-term growth, while others express concern about a possible shift to a bank-hybrid multiple. Discussions also include the potential impact on revenue streams and comparisons to other financial institutions.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is surging amid reports that an executive order to reclassify marijuana could be signed soon, potentially as early as this week. The community is buzzing about the implications of rescheduling for tax relief, research, and institutional investment, while also closely watching for official confirmation and potential market reactions. Some traders express caution due to past disappointments in the sector, while others see this as the start of a major upward trend.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors anticipate data and potential catalysts related to its immunology pipeline. Community discussions revolve around upcoming conference calls, data releases, and speculation about a potential buyout, particularly concerning the ongoing litigation with Eli Lilly. Traders are also actively monitoring technical indicators and analyst price targets, contributing to the increased attention surrounding NKTR.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid discussions about its valuation and potential acquisitions, with community members weighing the impact of AI on its business model. Some investors express frustration with the stock's recent performance despite strong earnings, while others see it as an undervalued AI play with long-term growth potential. The community is also closely watching for a potential stock split and its impact on the share price.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending due to community discussion around its explosive history and potential for a squeeze, particularly given its tight base as a biotech microcap. Traders are also closely monitoring price action and volume, speculating about possible M&A activity or partnership deals. The community is weighing the potential for downside risk against the possibility of exponential gains pending FDA approval or further clinical trial developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prima BioMed (NASDAQ:IMMP) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Prima BioMed from a "sell" rating to a "hold" rating in a research report on Saturday...

Prima BioMed (NASDAQ:IMMP) Share Price Passes Below 50-Day Moving Average - Time to Sell?

Prima BioMed (NASDAQ:IMMP) Stock Price Crosses Below 50 Day Moving Average - Here's Why...

Prima BioMed (NASDAQ:IMMP) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Prima BioMed (NASDAQ:IMMP) Stock Passes Above 50-Day Moving Average - Here's What Happened...

Prima BioMed (NASDAQ:IMMP) Share Price Passes Below 50 Day Moving Average - Here's Why

Prima BioMed (NASDAQ:IMMP) Share Price Passes Below 50 Day Moving Average - Here's Why...

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.

IMMP
Immutep LTD ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMMP News

IMMPImmutep LTD ADR